Voglimit MF Tablet
By Voglimit MF
Rx
10 Tablet in a Strip

Composition
Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Mitoch Pharma Pvt Ltd
F19, F20, F21, Kohinoor Mall, Opp. Don Bosco Engineering College, Kirol Road, Kurla (W), Mumbai - 400 070

Expires on or after
August, 2025
About Voglimit MF Tablet
Voglimit MF Tablet is categorized as an anti-diabetic drug specifically designed to help manage type 2 diabetes mellitus in adults. It is a combination of medicines carefully formulated to assist in controlling blood sugar levels for individuals with diabetes. This medication is most effective when taken with food on a consistent daily basis, at the same time each day. The appropriate dosage will be determined by your healthcare provider based on your individual needs and may be adjusted over time depending on how well it is controlling your blood sugar levels.
It is crucial to continue taking Voglimit MF Tablet as prescribed, even if you are feeling well or if your blood sugar levels seem stable. Abruptly discontinuing the medication without consulting your doctor can lead to a dangerous increase in blood sugar levels, potentially resulting in severe complications such as kidney damage, vision impairment, nerve issues, and even amputations. Remember, this medication is just one component of a comprehensive treatment plan that should also involve lifestyle modifications including a healthy diet, regular physical activity, and weight management as advised by your healthcare provider.
While Voglimit MF Tablet is generally well-tolerated, there are some common side effects that may occur such as nausea, changes in taste perception, reduced appetite, flatulence, stomach discomfort, diarrhea, and skin rashes. In most cases, these side effects are temporary and tend to resolve on their own. However, if you experience persistent or concerning side effects, it is important to seek advice from your doctor. They can provide guidance on managing or addressing these side effects to ensure your comfort and well-being throughout the course of treatment.
There are certain circumstances under which Voglimit MF Tablet may not be suitable for use. This includes individuals with type 1 diabetes mellitus, diabetic ketoacidosis (characterized by high acid levels in the blood), or severe kidney or liver disease. If you have a history of heart disease, it is essential to inform your doctor before starting this medication as it may not be recommended in such cases. Pregnant or breastfeeding women should also consult their healthcare provider before initiating treatment with Voglimit MF Tablet. Regular monitoring of blood sugar levels, as well as periodic blood tests to assess blood cell counts and liver function, may be advised by your doctor to ensure the medication is working effectively and safely for you.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹85
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024